for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Aldeyra Receives Orphan Medicinal Product Designation From European Commission For ADX-2191 Retinal Disease Program

June 15 (Reuters) - Aldeyra Therapeutics Inc:

* ALDEYRA THERAPEUTICS RECEIVES ORPHAN MEDICINAL PRODUCT DESIGNATION FROM EUROPEAN COMMISSION FOR ADX-2191 RETINAL DISEASE PROGRAM Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up